Depletion-restitution therapy for autoimmune rheumatic diseases. Part 1. Fundamental prerequisites and efficacy of modern treatment technologies: anti-B-cell drugs and CAR-T therapy
The key element in the pathogenesis of systemic autoimmune rheumatic diseases is the breakdown of immunological tolerance and the formation of a pool of autoreactive cells. This leads to uncontrolled activation of the effector arm of cellular (T-lymphocytes) and humoral (B-lymphocytes and plasma cel...
Saved in:
| Main Authors: | A. M. Lila, A. L. Maslyanskiy, D. A. Dibrov, A. V. Torgashina, E. G. Zotkin, M. Yu. Samsonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2025-04-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1734 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Depletion-restitution therapy of autoimmune rheumatic diseases. Part 2. Perspectives on bispecific antibodies
by: A. L. Maslyanskiy, et al.
Published: (2025-06-01) -
Different induction therapy protocols experience based on depleting antibodies for kidney transplantation
by: S. V. Arzumanov, et al.
Published: (2016-02-01) -
The effectiveness and safety of ofatumumab for the treatment of pemphigus vulgaris: a cohort study based on a registry database
by: Xiwen Zhang, et al.
Published: (2025-07-01) -
B-Cell-Depleting Immune Therapies as Potential New Treatment Options for Systemic Sclerosis
by: Gerhard Zugmaier, et al.
Published: (2025-01-01) -
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapy
by: Anika M. Valk, et al.
Published: (2025-04-01)